Alnylam Pharmaceuticals
ALNY
#624
Rank
C$56.36 B
Marketcap
C$422.17
Share price
3.78%
Change (1 day)
1.09%
Change (1 year)
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.

We have found no stock splits for this company